Table 1 Patient characteristics and clinical findings at presentation in children with community-acquired pneumonia
CharacteristicChildren with good quality sputum sample(n = 76)Children with poor quality sputum sample or quality of sputum sample not analysed(n = 25)Children without sputum induction(n = 32)
Age (years)*3.4 (1.7–6.8)7.5 (3.0–10.7)4.1 (2.0–7.5)
Male, n (%)36 (47%)15 (60%)15 (47%)
Underlying condition (%)24 (32%)8 (32%)16 (50%)
    Asthma12 (16%)6 (24%)3 (9%)
    Prematurity (gestational age ⩽36 weeks)6 (8%)0 (0%)1 (3%)
    Atopy2 (3%)0 (0%)1 (3%)
    Congenital heart disease2 (3%)0 (0%)2 (6%)
    Neurological disease2 (3%)2 (8%)13 (41%)
Ongoing antibiotic treatment on admission (%)11 (15%)5 (20%)8 (25%)
    Macrolide6 (8%)1 (4%)3 (9%)
    Beta-lactam3 (4%)4 (16%)3 (9%)
    Other2 (3%)0 (0%)2 (6%)
Symptoms and signs
    Fever ⩾38.0°C (%)74 (97%)25 (100%)30 (94%)
    Cough (%)72 (95%)23 (92%)25 (78%)
    Dyspnoea (%)27 (36%)8 (32%)8 (25%)
Inflammatory parameters
    CRP (mg/l)*128 (50–212)142 (39–259)107 (33–238)
    WBC count (×109/l)*18.6 (9.8–25.6)14.5 (7.2–22.6)12.0 (9.2–19.6)
Chest radiograph finding
    Alveolar infiltrates (%)67 (88%)21 (84%)29 (91%)
    Interstitial infiltrates (%)11 (15%)4 (16%)3 (9%)
    Pleural fluid (%)8 (11%)1 (4%)0 (0%)
  • *Median (interquartile range).

  • CRP, C-reactive protein; WBC, white blood cells.